Clinical Trial Update: External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL [Phase 1]

View source ↗

Summary

This Clinical Trials update describes a Phase 1 study evaluating external beam radiotherapy followed by a bispecific antibody therapy for relapsed or refractory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: University of Utah | Conditions: Diffuse Large B Cell Lymphoma | Phase 1 | Status: NOT_YET_RECRUITING